Generex Biotechnology (OTC: GNBT) CEO Interview
Generex Biotechnology (OTC: GNBT) CEO: Joe Moscato THIS INTERVIEW HAS EXPIRED
Generex Biotechnology (OTC: GNBT) CEO: Joe Moscato THIS INTERVIEW HAS EXPIRED
Marathon Gold Corp (TSX: MOZ) (OTCQX: MGDPF) CEO: Phil Walford About: Marathon is a Toronto based gold exploration company rapidly advancing its 100% owned Valentine Lake Gold Camp located in Newfoundland, one of the top […]
Citius Pharmaceuticals (NASDAQ: CTXR) CEO: Myron Holubiak About: Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and […]
“V-Go helps patients simplify their insulin therapy and improve their management of diabetes. With this decision to make V-Go Preferred by OptumRx, V-Go should be even more affordable for many patients with type 2 diabetes” […]
The Property covers 16,335 hectares (40,000 acres) in the Yukon’s White Gold District, bringing the Company’s total holdings in the White Gold District to 439,000 hectares (1,080,000 acres). […]
DURECT Corporation (NASDAQ:DRRX) President and CEO: Jim Brown THIS INTERVIEW HAS EXPIRED
Tecogen, Inc. (NASDAQ: TGEB) CEO: Benjamin Locke THIS INTERVIEW HAS EXPIRED
The Wall Street Analyzer recently interviewed David D’Onofrio, the CEO of White Gold Corporation (TSX.V: WGO) (US OTC – NASDAQ International: WHGOF) to discuss the company’s recent impressive drill results at their new Vertigo […]
ChineseInvestors.com, Inc (OTCQB: CIIX) CEO: Warren Wang THIS INTERVIEW HAS EXPIRED, PLEASE CHECK OUT OUR FEATURED INTERVIEW SECTION FOR OTHER EXCITING STORIES
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com